ACCESS to the Cardiac Catheterization Laboratory in Patients Without ST-segment Elevation Myocardial Infarction Resuscitated From Out-of-hospital Ventricular Fibrillation Cardiac Arrest

Status: Terminated
Location: See all (23) locations...
Intervention Type: Procedure, Diagnostic Test
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

To determine if survival to hospital discharge with good neurological outcome for adults ages 18-75 who are resuscitated from out-of-hospital VT/VF cardiac arrest without clinical signs of a heart attack do better by going straight to the cardiac catheterization laboratory or admitted to the intensive care unit for evaluation. The investigators think a large portion of resuscitated patients presenting with VT/VF have ischemic heart disease which is the cause for the arrest. And prompt access to the cardiac catheterization laboratory to reverse the blocked artery will improve survival with good neurological outcomes.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 75
Healthy Volunteers: No
View:

• Adult presumed or known to be 18-75 years old

• Resuscitated from OOHCA

• Initial cardiac arrest rhythm of pulseless VT/VF (including patients treated with an AED)

• No ST-segment elevation MI (No STEMI) (or STEMI-equivalent syndrome) on ED 12-lead ECG (as interpreted by a physician)

Locations
United States
Georgia
Grady Memorial Hospital
Atlanta
Indiana
Indiana University Health Methodist Hospital
Indianapolis
Michigan
University Hospital
Ann Arbor
St. Joseph Mercy Hospital
Ypsilanti
Minnesota
North Memorial Medical Center
Brooklyn Center
Fairview Southdale Hospital
Edina
Hennepin County Medical Center
Minneapolis
University of Minnesota Medical Center, Fairview
Minneapolis
Methodist Hospital
Saint Louis Park
Regions Hospital
Saint Paul
St. Joseph's Hospital
Saint Paul
Ohio
University of Cincinnati
Cincinnati
Pennsylvania
Allegheny General Hospital
Pittsburgh
University of Pittsburgh
Pittsburgh
Rhode Island
Miriam Hospital
Providence
Rhode Island Hospital
Providence
Texas
Parkland Memorial Hospital
Dallas
Utah
University of Utah
Salt Lake City
Virginia
Virginia Commonwealth University Hospital
Richmond
Washington
Harborview Medical Center
Seattle
Wisconsin
Medical College of Wisconsin Froedtert Hospital
Milwaukee
Other Locations
Canada
St. Paul's Hospital
Vancouver
Vancouver General Hospital
Vancouver
Time Frame
Start Date: December 12, 2017
Completion Date: November 26, 2019
Participants
Target number of participants: 65
Treatments
Experimental: Initial CCL admission
Admission to the CCL to evaluate the coronary artery disease
Active Comparator: Initial ICU admission
Admission to the ICU to be evaluated by clinical team and the clinical treatment will be decided by the admitting/attending team.
Authors
Arvind Venkat, Joseph Ornato, Justin Benoit, Johannes Brechtken, Scott Youngquist, Demetris Yannopoulos, Tom Aufderheide, Clifton Callaway, Ann Coumbe, Ravi Hira, Ahamed Idris, Antony Hsu, Michael Thomas, Louis Kohl, Lisa Merck, Lekshmi Kumar, Brian Grunau, Carmello Panetta, Ben Hunter, Mary Ann Peberdy
Sponsors
Leads: University of Minnesota

This content was sourced from clinicaltrials.gov

Similar Clinical Trials